InvestorsHub Logo
Followers 50
Posts 9048
Boards Moderated 1
Alias Born 01/13/2007

Re: KeepItRealistic post# 449

Tuesday, 02/27/2024 8:14:40 AM

Tuesday, February 27, 2024 8:14:40 AM

Post# of 549
As long as folks understand that the CEO was marketing this drugs for years, even before he was CEO here. He's had a long time to increase sales. It hasn't happened. This month's type C FDA meeting on the 26th will take some time to even hear back. That means less than a year left on the patent if the company's own filings are correct. I'm just projecting o/s based on the company paying their 13 monthly installments with shares as the 10k says is required. They have to pay with either shares or cash. They don't want to spend the cash they have I would imagine. If they have delayed the payments then its just a matter of time before the dilution occurs. Can someone tell me how they pay back the 15 million convertible note and the other 10.2 million note that is due in yearly installments without burning cash or significant dilution? I mean CEO videos are great but this isn't a start up situation. The drug was approved in 2012. That's why the patent runs out next year.

Only in the message board world when a poster states they could see the price move from current to over 2.25 would they be considered a short. Don't be the last man standing is my opinion.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PTPI News